dc.contributor.author |
Gusen, P |
|
dc.contributor.author |
Vernon, John M |
|
dc.date.accessioned |
2010-03-09T15:38:56Z |
|
dc.date.available |
2010-03-09T15:38:56Z |
|
dc.date.issued |
1974 |
|
dc.identifier.uri |
https://hdl.handle.net/10161/2004 |
|
dc.description.abstract |
The plan of this paper is as follows: First, we summarize and point out several problems
we found with Comanor's study. Section III presents the results from a two-equation
model that decomposes the technical change measure into an R and D component and a
marketing component. The final section is an analysis of the elasticity of technical
change with respect to firm size. The total elasticity is shown to consist of two
parts - a "direct" and an "indirect" effect of size. The indirect effect is the effect
on technical change of the increase in R and- D inputs (induced by an increase in
firm size). In this section we make use also of a maximum likelihood estimation technique
developed by Tobin (1958) for cases where the dependent variable is limited, as is
the case for our sample
|
|
dc.format.extent |
306941 bytes |
|
dc.format.mimetype |
application/pdf |
|
dc.language.iso |
en_US |
|
dc.publisher |
Review of Economics and Statistics |
|
dc.subject |
elasticity of technical change |
|
dc.title |
Technical Change and Firm Size: The Pharmaceutical Industry |
|
dc.type |
Journal article |
|